Minnesota Center Loses NSF Funds

MINNEAPOLIS—Officials at the Minnesota Supercomputer Center are providing 334 scientists with free computer time until the end of the month while the state's congressional delegation wages an uphill battle to restore the center's recent loss of funding from the National Science Foundation. The free time on the center's Cray II and Cyber 205 supercomputers was made available after NSF gave center president John Sell two days' notice in mid-February that his facility would receive no more fu

Written byJim Dawson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The free time on the center's Cray II and Cyber 205 supercomputers was made available after NSF gave center president John Sell two days' notice in mid-February that his facility would receive no more funding. Sell hopes that the state's congressmen, led by Rep. Martin Sabo (DMinn.), will somehow find federal money to support the center and its clients, but he admits the outlook is "gloomy."

Minnesota was one of three university sites chosen in 1984 in the first phase of NSF's effort to establish a national supercomputing network. In 1985 NSF selected five other sites for the second phase of its program, and notified Minnesota, Purdue and Colorado State universities that NSF support would end when their two-year grants expired. Minnesota obtained an extension into 1987, but the $1 million it was given (out of a request for $6.5 million) was used up quickly because of the heavy demand ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies